Related Experiment Video
Updated: Apr 23, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
Silencing of CDC42 inhibits neuroblastoma cell proliferation and transformation
Sora Lee1, Brian T Craig1, Carmelle V Romain1
1Department of Pediatric Surgery, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Abstract:
Cell division cycle 42 (CDC42), a small GTPase of the Rho-subfamily, regulates diverse cellular functions including proliferation, cytoskeletal rearrangement and even promotes malignant transformation. Here, we found that increased expression of CDC42 correlated with undifferentiated neuroblastoma as compared to a more benign phenotype. CDC42 inhibition decreased cell growth and soft agar colony formation, and increased cell death in BE(2)-C and BE(2)-M17 cell lines, but not in SK-N-AS. In addition, silencing of CDC42 decreased expression of N-myc in BE(2)-C and BE(2)-M17 cells. Our findings suggest that CDC42 may play a role in the regulation of aggressive neuroblastoma behavior.
Insights
Increased cell division cycle 42 (CDC42) expression correlates with aggressive neuroblastoma. Inhibiting CDC42 reduced tumor cell growth and increased cell death, suggesting CDC42 as a potential therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Cell division cycle 42 (CDC42) is a Rho-subfamily GTPase involved in cell proliferation, cytoskeletal dynamics, and malignant transformation.
- Aberrant CDC42 expression is implicated in various cancers, but its specific role in neuroblastoma progression remains unclear.
Purpose of the Study:
- To investigate the role of CDC42 in the pathogenesis and progression of neuroblastoma.
- To determine if CDC42 expression levels correlate with neuroblastoma differentiation and aggressiveness.
- To evaluate the therapeutic potential of targeting CDC42 in neuroblastoma cell lines.
Main Methods:
- Quantitative analysis of CDC42 expression in neuroblastoma cell lines with varying differentiation states.
- Inhibition of CDC42 activity using pharmacological inhibitors or gene silencing (siRNA).
- Assessment of cell proliferation, colony formation in soft agar, apoptosis, and N-myc expression following CDC42 manipulation.
Main Results:
- Elevated CDC42 expression was observed in undifferentiated, aggressive neuroblastoma cells compared to more benign phenotypes.
- CDC42 inhibition significantly reduced cell growth and soft agar colony formation in aggressive neuroblastoma cell lines (BE(2)-C, BE(2)-M17).
- Silencing CDC42 led to increased cell death and decreased expression of the oncogene N-myc in sensitive cell lines.
Conclusions:
- CDC42 plays a critical role in promoting the aggressive behavior of certain neuroblastoma subtypes.
- Targeting CDC42 may represent a viable therapeutic strategy for aggressive neuroblastoma.
- The findings highlight CDC42 as a potential biomarker for neuroblastoma prognosis and a therapeutic target.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Abnormal Proliferation
Negative Regulator Molecules
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

